Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition.
- Published in:
- Current Hypertension Reports, 2022, v. 24, n. 3, p. 67, doi. 10.1007/s11906-022-01170-z
- By:
- Publication type:
- Article
Works matching IS 15226417 AND DT 2022 AND VI 24 AND IP 3
Results: 3
1
2
The Burden of Resistant Hypertension Across the World.
- Published in:
- Current Hypertension Reports, 2022, v. 24, n. 3, p. 55, doi. 10.1007/s11906-022-01173-w
- By:
- Publication type:
- Article
3
Advances in the Pathophysiology and Management of Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.
- Published in:
- Current Hypertension Reports, 2022, v. 24, n. 3, p. 45, doi. 10.1007/s11906-022-01168-7
- By:
- Publication type:
- Article